• CLSI I/LA30-P

CLSI I/LA30-P

Immunoassay Interference by Endogenous Antibodies; Proposed Guideline, ILA30PE

Clinical and Laboratory Standards Institute, 03/01/2007

Publisher: CLSI

File Format: PDF

$125.00$250.19


Published:01/03/2007

Pages:40

Clinical and Laboratory Standards Institute document I/LA30-P - Immunoassay Interference by Endogenous Antibodies; Proposed Guideline presents information on the origin, nature, and prevalence of circulating endogenous antibodies, which cause interference with immunoassay results. The mechanisms of the interference along with some specific examples are included. To address the problem, recommendations for regulatory bodies, reagent manufacturers, and laboratorians are provided.

More CLSI standard pdf

CLSI H30-A2

CLSI H30-A2

Procedure for the Determination of Fibrinogen in Plasma; Approved Guideline, H30-A2

$122.00 $245.21

CLSI X03R

CLSI X03R

Implementing a Needlestick and Sharps Injury Prevention Program in the Clinical Laboratory, X03-R

$90.00 $180.00

CLSI GP05-A2

CLSI GP05-A2

Clinical Laboratory Waste Management; Approved Guideline, GP05A2

$146.00 $292.31

CLSI I/LA18-A2

CLSI I/LA18-A2

Specifications for Immunological Testing for Infectious Diseases; Approved Guideline-Second Edition, ILA18A2E

$90.00 $180.00